FOLD | Amicus Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	9.60 - 9.88
52 Week Range	9.02 - 14.57
Beta	0.60
Implied Volatility	51.14%
IV Rank	50.18%
Day's Volume	3,256,193
Average Volume	2,566,204
Shares Outstanding	298,806,000
Market Cap	2,928,298,800
Sector	Healthcare
Industry	Biotechnology
IPO Date	2007-05-31

Valuation
Profitability
Growth
Health
P/E Ratio	-28.82
Forward P/E Ratio	N/A
EPS	-0.34
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	500
Country	USA
Website	FOLD

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

FOLD's peers: CGC, INCY, DNLI, ARGX, HRMY, RARE, CRNX, ARVN, RVMD, KURA, MLYS, LEGN, CYTK, INBX, DICE, EWTX, KRTX, DYN, MREO, BPMC, AGIO, DAWN, BMRN, INVA, MRVI, OMER

*Chart delayed

Analyzing fundamentals for FOLD we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is exceptionally good and Health is frighteningly weak. For more detailed analysis please see FOLD Fundamentals page.

Watching at FOLD technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on FOLD Technicals page.